Calliditas Therapeutics AB reports results for the quarter ended in December - Earnings Summary

Calliditas Therapeutics AB

21/02/2024 11:03

* Calliditas Therapeutics AB  CALTX.ST  reported a quarterly
adjusted loss of 34 øre​​ per share for the quarter ended in
December, lower than the same quarter last year, when the
company reported EPS of -7 øre.  The mean expectation of
four analysts for the quarter was for a loss of SEK1.73 per
share. Wall Street expected results to range from SEK-2.32
to SEK-1.10 per share.
    * Revenue rose 5.2% to SEK451.56 million from a year ago;
analysts
expected SEK353.67 million. 
    * Calliditas Therapeutics AB's reported EPS for the quarter
was a
loss of 34 øre​.
    * The company reported a quarterly loss of SEK18.37 million.
    * Calliditas Therapeutics AB shares had fallen by 15.9% this
quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the
pharmaceuticals
peer group is  "buy."

Wall Street's median 12-month price target for Calliditas
Therapeutics AB is SEK230.00 
This summary was machine generated from LSEG data February 21 at
11:02 a.m. UTC. ​All figures in Swedish crowns unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      -1.73          -0.34          Beat
 Sep. 30 2023      -0.28          -3.14          Missed
 Jun. 30 2023      -2.15          -1.71          Beat
 Mar. 31 2023      -1.70          -3.49          Missed